Introduction

Timothy Syndrome (TS) is a rare and severe genetic disorder that is characterised by cardiac abnormalities but also affects multiple organs. First identified in 2004, it was initially linked via two major characteristics: a dangerous heart condition called long QT syndrome and syndactyly, a fusion of fingers or toes. Further research, however, has revealed a wide range of symptoms involving various organs and tissues. 

While cardiac symptoms, particularly long QT syndrome, remain the most prominent, patients with TS also experience hypoglycaemia, immune deficiencies, and neurodevelopmental disorders such as autism.¹ Unfortunately, due to the complexity and severity of associated complications, including immune dysfunction, the average life expectancy for TS patients is only two to three years.²

This article explores the link between TS and immune system dysfunction, with a focus on why affected individuals are more susceptible to infections. Understanding these risks can inform better medical care and preventive strategies.

Understanding Timothy syndrome

TS is an extremely rare condition, with fewer than 100 reported cases worldwide and an incidence of under 1 in a million.³ It is caused by a mutation in a gene called CACNA1C, which plays an essential role in regulating calcium levels. In most cases the mutation is de novo, meaning it is a “new” mutation, arising spontaneously, and is not inherited from either parent.

Differences in individual mutations can influence how TS presents. Since genes act as blueprints for proteins, changes in genes can lead to changes in proteins and the way they function. Certain changes in parts of a gene can lead to a protein being altered one way or another, which can impact how symptoms present. 

Differences in mutations in TS result in two major groupings, TS1 and TS2, although they both share major characteristics, including immune deficiency. Differences in when the mutation occurs during development can also result in a “mosaic pattern”, where some cells or tissues are affected but not others, resulting in different symptoms between those affected.¹

The CACNA1C gene is crucial for regulating calcium levels within cells. CACNA1C codes for a protein that acts as a building block for structures called calcium channels. Calcium channels are embedded in cell membranes and control the flow of calcium ions, which is essential for the function of many cell types, including cardiac, neuronal, pancreatic and immune cells. CACNA1C mutations affect calcium channels called Cav1.2.¹ The Cav1.2 channels help maintain heart rhythm, support neural communication, and regulate immune cell activation. As such, mutations disrupt calcium signalling across various tissues, leading to the multi-systemic nature of TS.⁴

TS results in a variety of symptoms. Approximately 70% of individuals with TS present with congenital heart abnormalities, particularly long QT syndrome or other arrhythmias, which can lead to sudden cardiac death. Other symptoms may include distinctive facial features (e.g. flat nasal bridge, low-set ears, micrognathia), dental anomalies, neurodevelopmental delays (including autism spectrum disorder), endocrine disturbances, and, notably, immune deficiencies.⁴

The immune system and its role in protection

The immune system is the body’s defence mechanism against “intruders” or pathogens, such as bacteria and viruses. It consists of various cells known as white blood cells and is broadly divided into two branches: innate immunity and adaptive immunity.⁵

Innate immunity

Innate immunity is the body’s first line of defence. The innate immune system acts quickly, but non-specifically, meaning the attacks are not targeted to specific types of pathogens. Your skin and sinuses work as physical barriers for pathogens and are part of innate immunity, together with certain types of white blood cells, such as:⁵

• Dendritic cells: Dendritic cells act like security guards, on the lookout for potential pathogens. When they detect something potentially harmful, they alert and recruit immune cells, kick-starting the immune response
• Monocytes: Monocytes are large white blood cells which transform into macrophages when an infection is detected
• Macrophages: The word macrophage literally means “large eater”, a perfect description for their role in immunity. Macrophages engulf and digest or break down pathogens, cleaning up the infection site. They can also emit signals to recruit more immune cells, like dendritic cells do
• Neutrophils: Neutrophils are fast-acting white blood cells that attack pathogens

Adaptive immunity

Adaptive immunity is more specialised, involving T-cells and B-cells. Adaptive immunity helps recognise specific pathogens and create targeted antibodies against them. It is also in charge of long-term immunity of “immune memory”.⁵

T-cells

T-cells are able to make more targeted and strategic attacks, compared to the white blood cells of the innate immune system. They do so using different types of T-cells: 

• Helper T-cells, which instruct other immune cells on how to fight the infection
• Killer T-cells, which directly attack infected or abnormal cells, such as those taken over by a virus
• Regulatory T-cells, which keep the immune system in check. They can emit chemical signals which can increase or decrease inflammation and immune system activity

B-cells

B-cells are the white blood cells responsible for the production of antibodies, special proteins that target specific bacteria or viruses. Once a B-cell encounters a pathogen, it transforms into what is known as a plasma cell, mass-producing antibodies that specifically target and neutralise the pathogen. Some B-cells also become memory cells, remembering specific pathogens and antibodies, and ensuring that the next time that pathogen is encountered, the adaptive immune response will be faster.

How Timothy syndrome affects the immune system

Around 30-40% of individuals affected with TS suffer from immunodeficiency and recurrent infections.⁶ However, some studies estimate the frequency of immunodeficiency in individuals affected with TS to be as high as 75%.⁷ Affected individuals often exhibit reduced counts of immune cells from both innate and adaptive branches, including neutrophils, T-cells, and B-cells. This makes the susceptibility to, or risk of infection, higher and their ability to fight it weaker.⁷ 

Cav1.2 channels are highly expressed in T-cells. Calcium levels are crucial for T-cell function, as the flow of calcium into T-cells is needed for their activation and consequent immune response. People with calcium channel deficiencies, such as individuals affected by TS, are unable to properly activate T-cells. This can lead to a dampened response from T-cells and adaptive immunity, leading to a reduced ability to fight off infections. Some individuals affected by TS also show increased inflammation, caused by the immune system, suggesting a dysregulation of regulatory T-cells, leading to an immune imbalance.⁸

Cav1.2 channels also play an important role in the activation of other immune cells, such as B cells, with individuals affected by TS reported to have abnormally low antibody counts and dendritic cells. They are also linked to macrophage development from monocytes. A recent study showed that calcium channel blockers had an anti-inflammatory effect, decreasing immune activity and impairing macrophage recruitment. This suggests that faulty calcium channels lead to immune deficiencies and explains why individuals affected by TS are at higher risk for infection.⁷ 

Susceptibility to infections in individuals affected by TS 

While the majority of TS deaths are due to cardiac problems, the second most common cause of death is sepsis, also known as systemic infection. The most common types of infections in TS patients include:⁹

• Respiratory infections, including pneumonia, sinus infections, and bronchitis
• Viral infections, such as influenza (the flu) and respiratory syncytial virus (RSV)
• Ear infections, such as chronic otitis media

In rare cases, localised infections can spread to the bloodstream, leading to a deadly systemic infection, sepsis. It is estimated that around 50% of individuals with TS will suffer from sepsis in their lifetime, as immune deficiencies put them at higher risk due to their inability to fight off infections. Children with TS tend to require frequent hospitalisation due to recurrent infections, and complications can often be severe due to other organ malfunctions, especially cardiac.¹⁰

Current and emerging treatment approaches

There is no known cure for TS, and treatment focuses on preventative measures and reducing complications. Strategies to address immune system dysfunction focus on preventative care, managing immune dysregulation, and quick, effective antibiotic treatment when necessary. Some preventative measures include regular vaccines to reduce the risk of severe infections, in some cases prophylactic antibiotics, given before infection to prevent common bacterial infections, and immune-boosting treatments, such as IV immunoglobulin, which boosts antibody levels, often low in individuals with TS, and helps fight infections.¹¹

Summary

• Timothy syndrome is a rare genetic condition that can affect many different organs and tissues, including the heart, brain, and immune system
• Immune deficiencies: TS affects calcium channels present in immune cells (e.g. T-cells, B-cells, neutrophils), making it harder to fight infections
• Common infections in TS patients: Pneumonia, bronchitis, viral infections, such as the flu, and ear infections
• There is no cure for TS. Treatment focuses on prevention and treating symptoms and complications
• With better infection prevention and treatment, TS patients can live a longer, healthier life